ArticleGlia2026
A Human Model of Oligodendrocyte Development Shows MCL-1 Influences Oligodendrocyte Morphogenesis.
Article in Glia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Oligodendrocytes are the myelinating cells of the central nervous system. Regulation of the early stages of oligodendrocyte development is critical to the function of the cell. Specifically, myelin sheath formation is an energetically demanding event that requires precision, as alterations may lead to dysmyelination. Fatty acid β-oxidation has been shown to be critical for the function of oligodendrocytes. We previously showed that myeloid cell leukemia-1 (MCL-1), a well-characterized anti-apoptotic protein, is required for the development of murine oligodendrocytes in vivo. Further, MCL-1 regulates long-chain fatty acid β-oxidation in cancer cells through its interaction with Acyl-CoA synthetase long-chain family member 1 (ACSL1), an enzyme responsible for the conversion of free long-chain fatty acids into fatty acyl-CoA esters. Here, we introduce an in vitro system to isolate human stem cell-derived oligodendrocyte progenitor cells (OPCs) and investigate the involvement of MCL-1 during human oligodendrocyte development. Using this system, we pharmacologically inhibited MCL-1 in OPCs to investigate its non-apoptotic function at this developmental stage. We also used a motor neuron-oligodendrocyte co-culture system to examine the downstream effects of MCL-1 at later developmental stages when oligodendrocytes begin to contact axons and generate myelin. We demonstrate that the mitochondrial network changes in human oligodendrocyte development resemble those reported in mouse tissue. Our findings point to MCL-1 as a critical factor essential for proper oligodendrocyte morphogenesis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.